118th Congress · HOUSE BILLBILL

H.R. 7384 — Creating Hope Reauthorization Act of 2024

“To amend the Federal Food, Drug, and Cosmetic Act to extend the authority of the Secretary of Health and Human Services to issue priority review vouchers to encourage treatments for rare pediatric diseases.”

Health

Introduced Feb 15, 2024

Last action Feb 16, 2024

Pipeline · Bill → Law

Step 1

Introduced

Feb 15, 2024

Step 2

Referred

Feb 16, 2024

E&C

Step 3

Committee

Step 4

House floor

Step 5

Senate

Step 6

Resolve Changes

Step 7

Signed

SummaryCRS Summary

This bill extends until FY2029 a Food and Drug Administration program that awards priority review vouchers to manufacturers of drugs that treat rare pediatric diseases. (A priority review voucher entitles the voucher holder to priority review of a single human drug application.)

Provisions · 2 sectionsIntroduced in House

Timeline · 3 actions

Feb 16, 2024

Referred to the Subcommittee on Health.

Feb 15, 2024

Introduced in House

Feb 15, 2024

Referred to the House Committee on Energy and Commerce.